Repligen | RGEN - 销售毛利



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.28B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


销售毛利 更改 日
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Bio Techne USD 222.15M 13.86M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Bruker USD 416M 36.2M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
General Electric Aerospace USD 4.46B 220M 2026-06
Henry Schein USD 1.03B 39M 2026-06
Illumina USD 770M 49M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pfizer USD -248M 11.29B 2026-06
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Standard Biotools USD 11.31M 74K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 490M 52M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03